Resisting Calls For More Freedom To Produce Generics For Export, Australia's IP Regime Is Safe For Now, But Generic Makers, Unions Ready For Battle
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - An earlier proposal put forth to legislators by generics maker Hospira to ease restrictions on producing generics for export has been shot down
You may also be interested in...
An Unexpected Foe Challenges Pharma In Aussie Generics-For-Export Battle
Generic manufacturers and labor groups in Australia say current patent legislation is handicapping industry's ability to compete on the world stage and that, if the status quo remains, manufacturing and jobs are likely to go elsewhere
Australia Department Of Innovation Releases 10-Year Plan On Pharma Strategy
PERTH, Australia - Australia's Minister for Innovation, Industry, Science and Research, Senator Kim Carr, has released a sweeping report that outlines a 10-year plan for the country's pharmaceutical and biotech industry
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).